TRAIL-R as a negative regulator of innate immune cell responses

Immunity

Volumn 21, Issue 6, 2004, Pages 877-889

  Diehl, Gretchen E ^a   Yue, Herman H ^a   Hsieh, Kristina ^a   Kuang, Anna A ^a   Ho, Mary ^a   Morici, Lisa A ^a   Lenz, Laurel L ^a   Cado, Dragana ^a   Riley, Lee W ^a   Winoto, Astar ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CYTOKINE; GAMMA INTERFERON; I KAPPA B ALPHA; INTERLEUKIN 12; RECEPTOR SUBTYPE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS; DENDRITIC CELL; EXPERIMENTAL MODEL; IMMUNOREGULATION; KNOCKOUT MOUSE; LYMPHOCYTE SUBPOPULATION; MACROPHAGE ACTIVATION; MOUSE; MYCOBACTERIUM; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RECEPTOR INTRINSIC ACTIVITY; RECEPTOR UPREGULATION;

AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS REGULATORY PROTEINS; BASE SEQUENCE; CYTOKINES; GENE DELETION; HERPESVIRIDAE INFECTIONS; IMMUNITY, NATURAL; LIGANDS; LIPOPOLYSACCHARIDES; MACROPHAGES; MEMBRANE GLYCOPROTEINS; MICE; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; MUROMEGALOVIRUS; MYCOBACTERIUM BOVIS; RECEPTORS, CELL SURFACE; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; RECEPTORS, TUMOR NECROSIS FACTOR; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TIME FACTORS; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 10344260656     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.immuni.2004.11.008     Document Type: Article

References (58)

1. Almasan A., Ashkenazi A. Apo2L/trail. apoptosis signaling, biology, and potential for cancer therapy Cytokine Growth Factor Rev. 14:2003;337-348
2. Andrews D.M., Andoniou C.E., Granucci F., Ricciardi-Castagnoli P., Degli-Esposti M.A. Infection of dendritic cells by murine cytomegalovirus induces functional paralysis. Nat. Immunol. 2:2001;1077-1084
3. Ashkenazi A., Dixit V.M. Apoptosis control by death and decoy receptors. Curr. Opin. Cell Biol. 11:1999;255-260
4. Barton G.M., Medzhitov R. Linking Toll-like receptors to IFN-alpha/beta expression. Nat. Immunol. 4:2003;432-433. a
5. Barton G.M., Medzhitov R. Toll-like receptor signaling pathways. Science. 300:2003;1524-1525. b
6. Barton G.M., Medzhitov R. Toll signaling. RIPping off the TNF pathway Nat. Immunol. 5:2004;472-474
7. Biron C.A. Initial and innate responses to viral infections-pattern setting in immunity or disease. Curr. Opin. Microbiol. 2:1999;374-381
8. Biron C.A., Nguyen K.B., Pien G.C., Cousens L.P., Salazar-Mather T.P. Natural killer cells in antiviral defense. function and regulation by innate cytokines Annu. Rev. Immunol. 17:1999;189-220
9. Bodmer J.-L., Holler N., Reynard S., Vinciguerra P., Schneider P., Juo P., Blenis J., Tschopp J. TRAIL receptor-2 signals apoptosis through FADD and caspase 8. Nat. Cell Biol. 2:2000;241-243
10. Chou A.H., Tsai H.F., Lin L.L., Hsieh S.L., Hsu P.I., Hsu P.N. Enhanced proliferation and increased IFN-gamma production in T cells by signal transduced through TNF-related apoptosis-inducing ligand. J. Immunol. 167:2001;1347-1352
11. Clarke P., Meintzer S.M., Gibson S., Widmann C., Garrington T.P., Johnson G.L., Tyler K.L. Reovirus-induced apoptosis is mediated by TRAIL. J. Virol. 74:2000;8135-8139
12. Cretney E., Takeda K., Yagita H., Glaccum M., Peschon J.J., Smyth M.J. Increased Susceptibility to Tumor Initiation and Metastasis in TNF-Related Apoptosis-Inducing Ligand-Deficient Mice. J. Immunol. 168:2002;1356-1361
13. Cretney E., Uldrich A.P., Berzins S.P., Strasser A., Godfrey D.I., Smyth M.J. Normal thymocyte negative selection in TRAIL-deficient mice. J. Exp. Med. 198:2003;491-496
14. Dalod M., Salazar-Mather T.P., Malmgaard L., Lewis C., Asselin-Paturel C., Briere F., Trinchieri G., Biron C.A. Interferon alpha/beta and interleukin 12 responses to viral infections. pathways regulating dendritic cell cytokine expression in vivo J. Exp. Med. 195:2002;517-528
15. Dalod M., Hamilton T., Salomon R., Salazar-Mather T.P., Henry S.C., Hamilton J.D., Biron C.A. Dendritic cell responses to early murine cytomegalovirus infection. subset functional specialization and differential regulation by interferon alpha/beta J. Exp. Med. 197:2003;885-898
16. Deng Y., Lin Y., Wu X. TRAIL-induced apoptosis requires Bax-dependent mitochondrial release of Smac/DIABLO. Genes Dev. 16:2002;33-45
17. Dokun A.O., Kim S., Smith H.R., Kang H.S., Chu D.T., Yokoyama W.M. Specific and nonspecific NK cell activation during virus infection. Nat. Immunol. 2:2001;951-956
18. Ezekowitz R.A., Gordon S. Down-regulation of mannosyl receptor-mediated endocytosis and antigen F4/80 in bacillus Calmette-Guerin-activated mouse macrophages. Role of T lymphocytes and lymphokines. J. Exp. Med. 155:1982;1623-1637
19. Griffith T.S., Wiley S.R., Kubin M.Z., Sedger L.M., Maliszewski C.R., Fanger N.A. Monocyte-mediated tumoricidal activity via the tumor necrosis factor-related cytokine, TRAIL. J. Exp. Med. 189:1999;1343-1354
20. Halaas O., Vik R., Ashkenazi A., Espevik T. Lipopolysaccharide induces expression of APO2 ligand/TRAIL in human monocytes and macrophages. Scand. J. Immunol. 51:2000;244-250
21. Heldwein K.A., Liang M.D., Andresen T.K., Thomas K.E., Marty A.M., Cuesta N., Vogel S.N., Fenton M.J. TLR2 and TLR4 serve distinct roles in the host immune response against Mycobacterium bovis BCG. J. Leukoc. Biol. 74:2003;277-286
22. Hilliard B., Wilmen A., Seidel C., Liu T.S., Goke R., Chen Y. Roles of TNF-related apoptosis-inducing ligand in experimental autoimmune encephalomyelitis. J. Immunol. 166:2001;1314-1319
23. Hoffmann A., Levchenko A., Scott M.L., Baltimore D. The IkappaB-NF-kappaB signaling module. temporal control and selective gene activation Science. 298:2002;1241-1245
24. Hu W.H., Johnson H., Shu H.B. Tumor necrosis factor-related apoptosis-inducing ligand receptors signal NF-kappaB and JNK activation and apoptosis through distinct pathways. J. Biol. Chem. 274:1999;30603-30610
25. Kamath A.T., Pooley J., O'Keeffe M.A., Vremec D., Zhan Y., Lew A.M., D'Amico A., Wu L., Tough D.F., Shortman K. The development, maturation, and turnover rate of mouse spleen dendritic cell populations. J. Immunol. 165:2000;6762-6770
26. Kayagaki N., Yamaguchi N., Nakayama M., Eto H., Okumura K., Yagita H. Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells. a novel mechanism for the antitumor effects of type IIFNs J. Exp. Med. 189:1999;1451-1460
27. Kingsley C., Winoto A. Cloning of GT box-binding proteins. a novel Sp1 multigene family regulating T-cell receptor gene expression Mol. Cell. Biol. 12:1992;4251-4261
28. Kischkel F.C., Lawrence D.A., Chuntharapai A., Schow P., Kim K.J., Ashkenazi A. Apo2L/TRAIL-dependent recruitment of endogenouse FADD and caspase-8 to death receptor 4 and 5. Immunity. 12:2000;611-620
29. Kuang A.A., Diehl G.E., Zhang J., Winoto A. FADD is required for DR4- and DR5-mediated apoptosis. lack of TRAIL-induced apoptosis in FADD-deficient mouse embryonic fibroblasts J. Biol. Chem. 275:2000;25065-25068
30. Lamhamedi-Cherradi S.E., Zheng S.J., Maguschak K.A., Peschon J., Chen Y.H. Defective thymocyte apoptosis and accelerated autoimmune diseases in TRAIL(-/-) mice. Nat. Immunol. 4:2003;255-260
31. Lin Y., Devin A., Rodriguez Y., Liu Z.G. Cleavage of the death domain kinase RIP by caspase-8 prompts TNF-induced apoptosis. Genes Dev. 13:1999;2514-2526
32. Lin Y., Devin A., Cook A., Keane M.M., Kelliher M., Lipkowitz S., Liu Z.-G. The death domain kinase RIP is essential for TRAIL (Apo2L)-induced activation of I-kappaB kinase and c-Jun N-terminal kinase. Mol. Cell. Biol. 20:2000;6638-6645
33. Locksley R.M., Killeen N., Lenardo M.J. The TNF and TNF receptor superfamilies. integrating mammalian biology Cell. 104:2001;487-501
34. Lum J.J., Pilon A.A., Sanchez-Dardon J., Phenix B.N., Kim J.E., Mihowich J., Jamison K., Hawley-Foss N., Lynch D.H., Badley A.D. Induction of cell death in human immunodeficiency virus-infected macrophages and resting memory CD4 T cells by TRAIL/Apo2l. J. Virol. 75:2001;11128-11136
35. Meylan E., Burns K., Hofmann K., Blancheteau V., Martinon F., Kelliher M., Tschopp J. RIP1 is an essential mediator of Toll-like receptor 3-induced NF-kappaB activation. Nat. Immunol. 5:2004;503-507
36. Muhlenbeck F., Haas E., Schwenzer R., Schubert G., Grell M., Smith C., Scheurich P., Wajant H. TRAIL/Apo2L activates c-Jun NH2-terminal kinase (JNK) via caspase-dependent and caspase-independent pathways. J. Biol. Chem. 273:1998;33091-33098
37. Nagata S. Fas ligand-induced apoptosis. Annu. Rev. Genet. 33:1999;29-55
38. Nagy A., Moens C., Ivanyi E., Pawling J., Gertsenstein M., Hadjantonakis A.K., Pirity M., Rossant J. Dissecting the role of N-myc in development using a single targeting vector to generate a series of alleles. Curr. Biol. 8:1998;661-664
39. Orange J.S., Biron C.A. An absolute and restricted requirement for IL-12 in natural killer cell IFN-gamma production and antiviral defense. Studies of natural killer and T cell responses in contrasting viral infections. J. Immunol. 156:1996;1138-1142. a
40. Orange J.S., Biron C.A. Characterization of early IL-12, IFN-alphabeta, and TNF effects on antiviral state and NK cell responses during murine cytomegalovirus infection. J. Immunol. 156:1996;4746-4756. b
41. Poltorak A., He X., Smirnova I., Liu M.Y., Van Huffel C., Du X., Birdwell D., Alejos E., Silva M., Galanos C., et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice. mutations in Tlr4 gene Science. 282:1998;2085-2088
42. Sato K., Hida S., Takayanagi H., Yokochi T., Kayagaki N., Takeda K., Yagita H., Okumura K., Tanaka N., Taniguchi T., Ogasawara K. Antiviral response by natural killer cells through TRAIL gene induction by IFN-alpha/beta. Eur. J. Immunol. 31:2001;3138-3146
43. Schneider P., Olson D., Tardivel A., Browning B., Lugovskoy A., Gong D., Dobles M., Hertig S., Hofmann K., Van Vlijmen H., et al. Identification of a new murine tumor necrosis factor receptor locus that contains two novel murine receptors for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). J. Biol. Chem. 278:2003;5444-5454
44. Song K.M., Chen Y.G., Goke R., Wilmen A., Seidel C., Goke A., Hilliard B., Chen Y.H. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is an inhibitor of autoimmune inflammation and cell cycle progression. J. Exp. Med. 191:2000;1095-1103
45. Sprick M.R., Weigand M.A., Rieser E., Rauch C.T., Juo P., Blenis J., Krammer P.H., Walczak H. FADD/MORT1 and caspase 8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2. Immunity. 12:2000;599-609
46. Takeda K., Kaisho T., Akira S. Toll-like receptors. Annu. Rev. Immunol. 21:2003;335-376
47. Takeda K., Smyth M.J., Cretney E., Hayakawa Y., Kayagaki N., Yagita H., Okumura K. Critical role for tumor necrosis factor-related apoptosis-inducing ligand in immune surveillance against tumor development. J. Exp. Med. 195:2002;161-169
48. Tay C.H., Welsh R.M. Distinct organ-dependent mechanisms for the control of murine cytomegalovirus infection by natural killer cells. J. Virol. 71:1997;267-275
49. Tomonari K., Fairchild S., Rosenwasser O.A. Influence of viral superantigens on V beta- and V alpha-specific positive and negative selection. Immunol. Rev. 131:1993;131-168
50. Walczak H., Miller R.E., Ariail K., Gliniak B., Griffith T.S., Kubin M., Chin W., Jones J., Woodward A., Le T., et al. Tumoricidal activity of tumor necrosis factor related apoptosis-inducing ligand in vivo. Nat. Med. 5:1999;157-163
51. Warschkau H., Kiderlen A.F. A monoclonal antibody directed against the murine macrophage surface molecule F4/80 modulates natural immune response to Listeria monocytogenes. J. Immunol. 163:1999;3409-3416
52. Wendling U., Walczak H., Dorr J., Jaboci C., Weller M., Krammer P.H., Zipp F. Expression of TRAIL receptors in human autoreactive and foreign antigen-specific T cells. Cell Death Differ. 7:2000;637-644
53. Wiley S.R., Schooley K., Smolak P.J., Din W.S., Huang C.-P., Nicholl J.K., Sutherland G.R., Smith T.D., Rauch C., Smith C.A., Goodwin R.G. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity. 3:1995;673-682
54. Woodland D.L., Happ M.P., Gollob K.J., Palmer E. An endogenous retrovirus mediating deletion of alpha beta T cells? Nature. 349:1991;529-530. a
55. Woodland D.L., Lund F.E., Happ M.P., Blackman M.A., Palmer E., Corley R.B. Endogenous superantigen expression is controlled by mouse mammary tumor proviral loci. J. Exp. Med. 174:1991;1255-1258. b
56. Wu G.S., Burns T.F., Zhan Y., Alnemri E.S., El-Deiry W.S. Molecular cloning and functional analysis of the mouse homologue of the KILLER/DR5 tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor. Cancer Res. 59:1999;2770-2775
57. Zheng S.J., Wang P., Tsabary G., Chen Y.H. Critical roles of TRAIL in hepatic cell death and hepatic inflammation. J. Clin. Invest. 113:2004;58-64
58. Zhou T., Edwards C.K. 3rd, Yang P., Wang Z., Bluethmann H., Mountz J.D. Greatly accelerated lymphadenopathy and autoimmune disease in lpr mice lacking tumor necrosis factor receptor I. J. Immunol. 156:1996;2661-2665